Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe record history now lists a new latest revision: v3.6.6, replacing v3.6.5. This indicates a minor update to the study record history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This reflects a maintenance update to the record history rather than changes to the study data.SummaryDifference0.1%

- Check39 days agoChange Detected- The history now includes a new page revision entry for v3.6.4, replacing v3.6.3. This indicates an update to the page's record.SummaryDifference0.1%

- Check60 days agoChange DetectedNew revision number v3.6.3 is now shown, replacing the previous v3.6.2. This indicates the study record has been updated to a newer version, reflecting changes since the prior revision.SummaryDifference0.1%

- Check67 days agoChange DetectedThe revision history now shows a new revision entry (v3.6.2). This update reflects an update to the page's versioning record rather than substantive content changes.SummaryDifference0.1%

- Check74 days agoChange DetectedA new References section has been added to the study record page, listing sources cited in the record to support the information presented.SummaryDifference0.1%

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.